Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia

Journal:
The New England Journal of Medicine
Published:
Affiliations:
25
Authors:
34
Institutions Authors Share
Leeds Cancer Research UK Clinical Trials Unit, United Kingdom (UK)
9.000000
0.26
Leeds Cancer Centre, LTHT, United Kingdom (UK)
5.000000
0.15
Oxford University Hospitals NHS Trust (OUH), United Kingdom (UK)
2.000000
0.06
University Hospital of Wales, United Kingdom (UK)
2.000000
0.06
University College London Hospitals NHS Foundation Trust (UCLH), United Kingdom (UK)
1.000000
0.03
University Hospitals Birmingham NHS Foundation Trust (UHB), United Kingdom (UK)
1.000000
0.03
University Hospitals Dorset NHS Foundation Trust, United Kingdom (UK)
1.000000
0.03
Queen Mary University of London (QMUL), United Kingdom (UK)
1.000000
0.03
Leeds Institute of Medical Research at St James's (LIMR), University of Leeds, United Kingdom (UK)
1.000000
0.03
Belfast City Hospital, BHSCT, United Kingdom (UK)
1.000000
0.03
Aberdeen Royal Infirmary, NHS Grampian, United Kingdom (UK)
1.000000
0.03
CLL Support Association, United Kingdom (UK)
1.000000
0.03
University Hospitals of Leicester NHS Trust (UHL), United Kingdom (UK)
1.000000
0.03
Worcestershire Acute Hospitals NHS Trust, United Kingdom (UK)
1.000000
0.03
The University of Nottingham (UoN), United Kingdom (UK)
1.000000
0.03
Hull University Teaching Hospitals NHS Trust, United Kingdom (UK)
1.000000
0.03
The Clatterbridge Cancer Centre NHS Foundation Trust, United Kingdom (UK)
0.500000
0.01
University of Southampton (Soton), United Kingdom (UK)
0.500000
0.01
The Christie NHS Foundation Trust, United Kingdom (UK)
0.500000
0.01
King's College Hospital NHS Foundation Trust, United Kingdom (UK)
0.500000
0.01
King's College London (KCL), United Kingdom (UK)
0.500000
0.01
University of Liverpool, United Kingdom (UK)
0.500000
0.01
The University of Manchester (UoM), United Kingdom (UK)
0.500000
0.01
University Hospital Southampton NHS Foundation Trust, United Kingdom (UK)
0.500000
0.01